SEC Form 4 · accession 0001548242-15-000005
Yew Bio-Pharm Group, Inc. · YEWB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Guifang Qi
Officer — Treasurer · Director
Period of report
Mar 18, 2015
Accepted (ET)
Mar 23, 2015 · 6:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001548240
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 18, 2015 | S | 10,000 | $0.29 | D | 2,449,737 | D | |
| Common Stock | Mar 19, 2015 | S | 10,000 | $0.29 | D | 2,439,737 | D |
Table II — derivative securities
No Table II lines on this filing.